SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

AGM Trading Update

26 Oct 2009 07:00

RNS Number : 3328B
City of London Investment Group PLC
26 October 2009
 



26 October 2009

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

Annual General Meeting

Trading Update

The MSCI Emerging Markets Index (MXEF) has appreciated from 870 at the time that our Report and Accounts were prepared to around 960 at 22nd October. During this period funds under management ("FUM") have increased from $4.0 billion to $4.8 billion. This growth reflects the funding of around $350 million of the $500 million new mandates that were referred to by the Company's chief executive, Barry Olliff, in the Report and Accounts. We are still to receive slightly in excess of $150 million. Against this, however, it is likely that rebalancing activity may increase in the event that the emerging markets continue to outperform at the rate they have recently achieved.

With FuM rising from $3.5 billion at the start of the financial year to $4.7 billion at the end of September, unaudited profit before taxation for the first four months of the year stands at £2.9 million, matching that of the equivalent period last year. In sterling terms FuM now stands at £2.9 billion, some 20% above the previous peak in late 2007, and unaudited profit as measured in terms of monthly run-rate has also advanced to a new high. Clearly it is to be hoped that the coming months do not see a return to the volatility experienced last year, and that the steady growth enjoyed in the year to date is sustained.

We have continued to defer our intended upgrade to a full listing, determining that this should be reviewed following the end of the financial year within the context of full year profit and prospective dividend.

As the founding and largest shareholder, Barry Olliff has a stated policy of transparency about his intentions regarding his shareholding, and this is an approach which the Board considers to be very helpful. Barry increased his holding of Company shares in the previous year by 231,103 shares, through a mix of market purchases and option exercises, to the current level of 5,243,683 shares. Now, in the event that the Company's share price achieves 310p he intends to sell 500,000 shares, and he would intend, subject to close period restrictions and other regulatory requirements, to undertake the same at 350p and 400p. Should these intentions alter, perhaps as a result of a material change in market conditions, Barry has undertaken to inform the Board promptly, and an appropriate announcement will be released forthwith.

For the benefit of shareholders a recent shareholder presentation has today been added to our web site.

-ends-

 

Doug Allison (Finance Director)

Simon Hudson / Andrew Dunn

City of London Investment Group PLC

Tavistock Communications

Tel: +44 (0) 20 7860 8347

Tel: +44 (0)20 7920 3150

Jeff Keating 

Jeremy Ellis / Chris Sim

Singer Capital Markets Ltd

Evolution Securities Limited

Nominated Adviser & Joint Broker

Joint Broker

Tel: +44 (0)20 3205 7500

Tel: +44 (0)20 7071 4300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUGWGUUPBGQW
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.